Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

227 ARTÍCULOS , VIENDO DEL 211 AL 225

Combined therapeutic application of botulinum toxin type A, low-frequency rTMS, and intensive occupational therapy for post-stroke spastic upper limb hemiparesis

Kakuda W, Abo M, Momosaki R, Yokoi A, Fukuda A, Ito H, Tominaga A, Umemori T, Kameda Y.

Eur J Phys Rehabil Med. 2012 Mar;48(1):47-55. Epub 2011 Nov 9.

Immediate effects of electrical stimulation combined with passive locomotion-like movement on gait velocity and spasticity in persons with hemiparetic stroke: a randomized controlled study

Yamaguchi T, Tanabe S, Muraoka Y, Masakado Y, Kimura A, Tsuji T, Liu M.

Clin Rehabil. 2012 Jul;26(7):619-28. doi: 10.1177/0269215511426803. Epub 2011 Nov 16.

Effectiveness of functional progressive resistance exercise training on walking ability in children with cerebral palsy: a randomized controlled trial

Scholtes VA, Becher JG, Janssen-Potten YJ, Dekkers H, Smallenbroek L, Dallmeijer AJ.

Res Dev Disabil. 2012 Jan-Feb;33(1):181-8. doi: 10.1016/j.ridd.2011.08.026. Epub 2011 Oct 11.

Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study

Frasson E, Dall'ora E, Bordignon M, Brigo F, Tocco P, Primon D, Didonè G, Vicentini S, Fiaschi A, Bertolasi L.

J Child Neurol. 2012 May;27(5):587-93. doi: 10.1177/0883073811420874. Epub 2011 Nov 23.

Assessment of a portable device for the quantitative measurement of ankle joint stiffness in spastic individuals

Lorentzen J, Grey MJ, Geertsen SS, Biering-Sørensen F, Brunton K, Gorassini M, Nielsen JB.

Clin Neurophysiol. 2012 Jul;123(7):1371-82. doi: 10.1016/j.clinph.2011.11.001. Epub 2011 Nov 25.

Spasticity improvement in patients with relapsing-remitting multiple sclerosis switching from interferon-β to glatiramer acetate: the Escala Study

Meca-Lallana JE, Balseiro JJ, Lacruz F, Guijarro C, Sanchez O, Cano A, Costa-Frossard L, Hernández-Clares R, Sanchez-de la Rosa R; Escala Study Group.

J Neurol Sci. 2012 Apr 15;315(1-2):123-8. doi: 10.1016/j.jns.2011.11.010. Epub 2011 Nov 30.

Paradoxical worsening of spasticity and pain in the lower extremities after increasing the dose of intrathecal baclofen--case report

Murakami M, Hirata Y, Kuratsu J.

Neuromodulation. 2012 Jan-Feb;15(1):39-40; discussion 41. doi: 10.1111/j.1525-1403.2011.00409.x. Epub 2011 Dec 12.

Cycling exercise with functional electrical stimulation improves postural control in stroke patients

Lo HC, Hsu YC, Hsueh YH, Yeh CY.

Gait Posture. 2012 Mar;35(3):506-10. doi: 10.1016/j.gaitpost.2011.11.017. Epub 2011 Dec 6.

Effects of afferent stimulation rate on inhibitory spinal pathways in hemiplegic spastic patients

Roche N, Achache V, Lackmy A, Pradat-Diehl P, Lamy JC, Katz R.

Clin Neurophysiol. 2012 Jul;123(7):1391-402. doi: 10.1016/j.clinph.2011.11.006. Epub 2011 Dec 15.

Neurophysiological evaluation of segmental motor neuron function of the thoracic cord in chronic SCI

Frostell A, Mattsson P, Persson JK, Hedman B, Nordblom J, Lindenryd A, Trok K, Brundin L, Svensson M.

Spinal Cord. 2012 Apr;50(4):315-9. doi: 10.1038/sc.2011.155. Epub 2011 Dec 20.

Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity

Doan QV, Brashear A, Gillard PJ, Varon SF, Vandenburgh AM, Turkel CC, Elovic EP.

PM R. 2012 Jan;4(1):4-10. doi: 10.1016/j.pmrj.2011.10.001. Epub 2011 Dec 24.

Gap junctions in inherited human disorders of the central nervous system

Abrams CK, Scherer SS.

Biochim Biophys Acta. 2012 Aug;1818(8):2030-47. doi: 10.1016/j.bbamem.2011.08.015. Epub 2011 Aug 16.

Botulinum toxin A treatment of Raynaud's phenomenon: a review

Iorio ML, Masden DL, Higgins JP.

Semin Arthritis Rheum. 2012 Feb;41(4):599-603. doi: 10.1016/j.semarthrit.2011.07.006. Epub 2011 Aug 24.

Five-year experience with incobotulinumtoxinA (Xeomin(®) ): the first botulinum toxin drug free of complexing proteins

Dressler D.

Eur J Neurol. 2012 Mar;19(3):385-9. doi: 10.1111/j.1468-1331.2011.03559.x. Epub 2011 Oct 28.

Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3

Horvath R, Czermin B, Gulati S, Demuth S, Houge G, Pyle A, Dineiger C, Blakely EL, Hassani A, Foley C, Brodhun M, Storm K, Kirschner J, Gorman GS, Lochmüller H, Holinski-Feder E, Taylor RW, Chinnery PF.

J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):174-8. doi: 10.1136/jnnp-2011-301258. Epub 2011 Oct 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias